Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHi 621 in renal transplantation
Kovarik, J.M.; Rawlings, E.; Sweny, P.; Fernando, O.; Moore, R.; Griffin, P.J.; Fauchald, P.; Albrechtsen, D.; Sodal, G.; Nordal, K.; Amlot, P.L.
Transplantation Proceedings 28(2): 913-914
1996
ISSN/ISBN: 0041-1345 PMID: 8623459 Document Number: 457294
Document emailed within 1 workday
Related Documents
Wonigeit, K.; Nashan, B.; Schwinzer, R.; Schlitt, H.J.; Kurrle, R.; Racenberg, J.; Seiler, F.; Ringe, B.; Pichlmayr, R. 1989: Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation Transplantation Proceedings 21(1 Part 2): 2258-2259Yoshimura, N.; Lee, C.J.; Shiho, O.; Kita, M.; Imanishi, J.; Oka, T. 1995: Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells Transplantation Proceedings 27(1): 390-391
Alegre, M.L.; Collins, A.M.; Pulito, V.L.; Brosius, R.A.; Olson, W.C.; Zivin, R.A.; Knowles, R.; Thistlethwaite, J.R.; Jolliffe, L.K.; Bluestone, J.A. 1992: Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody Journal of Immunology 148(11): 3461-3468
Tax, W.J.; van de Heijden, H.M.; Willems, H.W.; Hoitsma, A.J.; Berden, J.H.; Capel, P.J.; Koene, R.A. 1987: Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation Transplantation Proceedings 19(1 Part 3): 1905-1907
Moroz, C.; Zaspin, E.; Shohat, B. 1996: An immunosuppressive effect of anti-p43 monoclonal antibody on human xenogeneic graft versus host response is mediated by CD8+ T cells Transplantation Proceedings 28(6): 3196-3198
Sumimoto, R.; Kamada, N. 1991: Immunosuppressive effect of soluble class i antigen and its complexes with monoclonal antibody on advanced heart graft rejection in rats Transplantation Proceedings 23(1 Part 1): 86-88
Hirsch, R.; Bluestone, J.A.; Bare, C.V.; Gress, R.E. 1991: Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice Transplantation Proceedings 23(1 Part 1): 270-271
Tao, L.; Rao, C.-M.; Gao, K.; Shi, X.-C.; Zhao, Y.; Wang, J.-Z. 2010: Structure verification of a recombinant chimeric anti-CD20 IgG1 monoclonal antibody Yao Xue Xue Bao 45(6): 752-755
Velders, M.P.; Litvinov, S.V.; Warnaar, S.O.; Gorter, A.; Fleuren, G.J.; Zurawski, V.R.; Coney, L.R. 1994: New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency Cancer Research 54(7): 1753-1759
Chattopadhyay, P.; Kaveri, S.V.; Byars, N.; Starkey, J.; Ferrone, S.; Raychaudhuri, S. 1991: Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1 Cancer Research 51(22): 6045-6051
McQuarrie, S.A.; Baum, R.P.; Golberg, L.; Niesen, A.; Golberg, K.; Noujaim, A.A.; McEwan, A.J. 1994: A pharmacokinetic comparison of murine and chimeric forms of the 99mTc-labelled 174H.64 monoclonal antibody Journal of Nuclear Biology and Medicine 38(4 Suppl 1: 140-144
Nocera, A.; Cosimi, A.B.; Colvin, R.B.; Gesner, M.L.; Fuller, T.C. 1988: Phenotypic and functional analysis of kidney infiltrating T cells escaping monoclonal antibody treatment in primate renal transplantation Transplantation Proceedings 20(2): 205-206
Harkonen, S.; Stoudemire, J.; Mischak, R.; Spitler, L.E.; Lopez, H.; Scannon, P. 1987: Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin a chain immunotoxin in rats Cancer Research 47(5): 1377-1382
Antoni, C.; Kalden, J.R. 1999: Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 17(6 Suppl 18: S73-S77
Pearson, T.C.; Madsen, J.C.; Wood, K.J. 1991: Effect of anti-CD4 monoclonal antibody dosage when combined with donor antigen for the induction of transplantation tolerance Transplantation Proceedings 23(1 Part 1): 565-566
Zhou, T.; Li, X.; Wu, P.; Zhang, D.; Zhang, M.; Chen, N.; Dong, D. 2000: Effect of anti-P-selectin monoclonal antibody on renal ischemia/reperfusion injury in rats Chinese Medical Journal 113(9): 790-793
Chen, B.; Cai, X.J.; Zhou, S.J. 1994: Antitumor activity of monoclonal antibody MI2 against immunosuppressive acidic protein in vitro Zhonghua Nei Ke Za Zhi 33(8): 531-533
Lee, C.J.; Yoshimura, N.; Hamashima, T.; Ohsaka, Y.; Oka, T. 1990: Effect of selective administration of monoclonal anti-T-cell antibody on renal allografts in RAT: preliminary report Nihon Geka Gakkai Zasshi 91(10): 1658
Dewerchin, M.; Vandamme, A.M.; Holvoet, P.; De Cock, F.; Lemmens, G.; Lijnen, H.R.; Stassen, J.M.; Collen, D. 1992: Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase Thrombosis and Haemostasis 68(2): 170-179
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216